Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Nastech Pharmaceutical Company Inc. patentsThe following is a sampling of recent Nastech Pharmaceutical Company Inc. patent applications (USPTO Patent Application #, Patent Title) sorted by month.
April 2008 - Nastech Pharmaceutical Company Inc. patents
20080096769 - Phage displayed trp cage ligands
March 2008 - Nastech Pharmaceutical Company Inc. patents
20080076701 - Dicer substrate rna peptide conjugates and methods for rna therapeutics
February 2008 - Nastech Pharmaceutical Company Inc. patents
20080051332 - Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
20080029084 - Device for improved peptide delivery
January 2008 - Nastech Pharmaceutical Company Inc. patents
20080004218 - Methods for enhanced epithelial permeation of y2 receptor-binding peptides for treating and preventing obesity
December 2007 - Nastech Pharmaceutical Company Inc. patents
20070293449 - Compositions and methods for delivery of double-stranded rna
20070293657 - Complexes and methods of forming complexes of ribonucleic acids and peptides
20070281900 - Compositions and methods for lipid and polypeptide based sirna intracellular delivery
November 2007 - Nastech Pharmaceutical Company Inc. patents
20070275923 - Cationic peptides for sirna intracellular delivery
20070275893 - Compositions for enhanced epithelial permeation of peptide yy for treating obesity
20070276134 - Compositions and methods for complexes of nucleic acids and organic cations
20070269892 - Formulations for intracellular delivery dsrna
20070253956 - Method for opening tight junctions
20070254362 - Compositions and methods employing universal-binding nucleotides for targeting multiple gene variants with a single sirna duplex
October 2007 - Nastech Pharmaceutical Company Inc. patents
20070244049 - Compositions and methods for enhanced mucosal delivery of parathyroid hormone
20070232537 - Intranasal pyy formulations with improved transmucosal pharmacokinetics
September 2007 - Nastech Pharmaceutical Company Inc. patents
20070212306 - Intranasal formulations of interferon beta free of stabilizers that are proteins or polypeptides
20070213293 - Rnai therapeutic for respiratory virus infection
20070213257 - Compositions and methods for complexes of nucleic acids and peptides
20070213270 - Peptide yy formulations having increased stability and resistance to microbial agents
August 2007 - Nastech Pharmaceutical Company Inc. patents
20070203165 - Compounds and methods for lowering the abuse potential and extending the duration of action of a drug
20070197444 - Phage displayed cell binding peptides
20070197437 - Compositions for enhanced epithelial permeation of y2 receptor-binding peptides
20070185035 - Enhanced mucosal administration of neuroprotective peptides
July 2007 - Nastech Pharmaceutical Company Inc. patents
20070172430 - Dry powder compositions for rna influenza therapeutics
20070173447 - Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent
20070167364 - Compositions and methods for enhanced mucosal delivery of parathyroid hormone
20070161563 - A device for enhanced epithelial permeation of y2 receptor-binding peptides
20070154400 - Compositions and methods for enhanced mucosal delivery of parathyroid hormone
20070154401 - Compositions and methods for enhanced mucosal delivery of parathyroid hormone
20070154449 - Tight junction modulating peptides for enhanced mucosal delivery of therapeutic compounds
20070155658 - Nanoparticles for delivery of nucleic acids and stable double-stranded rna
June 2007 - Nastech Pharmaceutical Company Inc. patents
20070142291 - Methods for treating irritable bowel syndrome
20070129299 - Compositions and methods for enhanced mucosal delivery of pyy peptide
April 2007 - Nastech Pharmaceutical Company Inc. patents
20070077283 - Method of enhancing transmucosal delivery of therapeutic compounds
February 2007 - Nastech Pharmaceutical Company Inc. patents
20070032410 - Compositions and methods for the treatment of psychiatric disorders
September 2006 - Nastech Pharmaceutical Company Inc. patents
20060210614 - Method of treatment of a metabolic disease using intranasal administration of exendin peptide
August 2006 - Nastech Pharmaceutical Company Inc. patents
20060193871 - Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
20060189533 - Stable pharmaceutical dosage forms of teriparatide
July 2006 - Nastech Pharmaceutical Company Inc. patents
20060160123 - Method of minimizing off-target effects of sirna molecules
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Nastech Pharmaceutical Company Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Nastech Pharmaceutical Company Inc. with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
